A Study to Evaluate the Efficacy and Safety of KSI-301, an Anti-VEGF Antibody Biopolymer Conjugate, Versus Aflibercept in Patients With Neovascular (Wet) Age-Related Macular Degeneration.
Clinical trial NCT04049266 · TERMINATED
Trial details
- NCT number
- NCT04049266
- Sponsor
- Kodiak Sciences Inc
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-08
- Primary completion
- 2021-11-17
- Enrollment
- 559
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.